312 related articles for article (PubMed ID: 15637079)
1. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
3. Negative modulation of androgen receptor transcriptional activity by Daxx.
Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
[TBL] [Abstract][Full Text] [Related]
4. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.
Tang J; Wu S; Liu H; Stratt R; Barak OG; Shiekhattar R; Picketts DJ; Yang X
J Biol Chem; 2004 May; 279(19):20369-77. PubMed ID: 14990586
[TBL] [Abstract][Full Text] [Related]
5. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
6. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
7. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
[TBL] [Abstract][Full Text] [Related]
8. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation.
Zheng G; Yang YC
J Biol Chem; 2004 Oct; 279(41):42410-21. PubMed ID: 15280358
[TBL] [Abstract][Full Text] [Related]
9. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
[TBL] [Abstract][Full Text] [Related]
10. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation.
Chang CC; Naik MT; Huang YS; Jeng JC; Liao PH; Kuo HY; Ho CC; Hsieh YL; Lin CH; Huang NJ; Naik NM; Kung CC; Lin SY; Chen RH; Chang KS; Huang TH; Shih HM
Mol Cell; 2011 Apr; 42(1):62-74. PubMed ID: 21474068
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
[TBL] [Abstract][Full Text] [Related]
14. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration.
Lin DY; Shih HM
J Biol Chem; 2002 Jul; 277(28):25446-56. PubMed ID: 11948183
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
Ueki N; Hayman MJ
J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
[TBL] [Abstract][Full Text] [Related]
16. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
[TBL] [Abstract][Full Text] [Related]
17. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential.
Lin DY; Lai MZ; Ann DK; Shih HM
J Biol Chem; 2003 May; 278(18):15958-65. PubMed ID: 12595526
[TBL] [Abstract][Full Text] [Related]
19. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation.
Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T
J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774
[TBL] [Abstract][Full Text] [Related]
20. Physical and functional interactions between Daxx and TSG101.
Muromoto R; Sugiyama K; Yamamoto T; Oritani K; Shimoda K; Matsuda T
Biochem Biophys Res Commun; 2004 Apr; 316(3):827-33. PubMed ID: 15033475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
